Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « Titre (en) » - entrée « treatment »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
treating < treatment < treatments  Facettes :

List of bibliographic references indexed by treatment

Number of relevant bibliographic references: 203.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000108 (2011) Twenty Fifth Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders
000109 (2011) Elina Tripoliti [Royaume-Uni] ; Laura Strong [Royaume-Uni] ; Freya Hickey [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Joseph Candelario [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni]Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease
000110 (2011) P. Barone [Italie]Treatment of depressive symptoms in Parkinson’s disease
000111 (2011) J. FinstererTreatment of central nervous system manifestations in mitochondrial disorders
000152 (2011) F. Valldeoriola ; C. Coronell [Espagne] ; C. Pont ; M. T. Buongiorno ; A. Cámara ; C. Gaig ; Y. ComptaSocio‐demographic and clinical factors influencing the adherence to treatment in Parkinson’s disease: the ADHESON study
000155 (2011) Carl E. Clarke [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni]Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?
000186 (2011) Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada]Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts
000191 (2011) K. Kalinderi [Grèce] ; L. Fidani [Grèce] ; Z. Katsarou [Grèce] ; S. Bostantjopoulou [Grèce]Pharmacological treatment and the prospect of pharmacogenetics in Parkinson’s disease
000222 (2011) Laura Marsh [États-Unis] ; Constantine Lyketsos [États-Unis] ; Stephen G. Reich [États-Unis]Olanzapine for the Treatment of Psychosis in Patients With Parkinsons Disease and Dementia
000260 (2011) Rebecca Stowe [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Kelly Handley [Royaume-Uni] ; Alexandra Furmston [Royaume-Uni] ; Katherine Deane [Royaume-Uni] ; J. J. Van Hilten [Pays-Bas] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni]Meta‐analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease
000268 (2011) Elisa Garbayo [Espagne] ; Eduardo Ansorena [Espagne] ; Jose Luis Lanciego [Espagne] ; María Jose Blanco-Prieto [Espagne] ; María S. Aymerich [Espagne]Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease
000355 (2011) Aristide Merola [Italie] ; Maurizio Zibetti [Italie] ; Serena Angrisano [Italie] ; Laura Rizzi [Italie] ; Michele Lanotte [Italie] ; Leonardo Lopiano [Italie]Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease
000394 (2011) Eri Himeno [Japon] ; Yasumasa Ohyagi [Japon] ; Linqing Ma [Japon] ; Norimichi Nakamura [Japon] ; Katsue Miyoshi [Japon] ; Nobutaka Sakae [Japon] ; Kyoko Motomura [Japon] ; Naoko Soejima [Japon] ; Ryo Yamasaki [Japon] ; Tetsuya Hashimoto [Japon] ; Takeshi Tabira [Japon] ; Frank M. Laferla [États-Unis] ; Jun-Ichi Kira [Japon]Apomorphine treatment in Alzheimer mice promoting amyloid‐β degradation
000407 (2011) Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse]AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials
000524 (2010) David J. Burn [Royaume-Uni]The Treatment of Cognitive Impairment Associated with Parkinson's Disease
000547 (2010) Hanne Madsen [Danemark] ; Kim Brixen [Danemark] ; Jesper Hallas [Danemark]Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease – a population‐based database study
000578 (2010) Program: Twenty Fourth Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders
000585 (2010) Raquel Duran [Espagne] ; Francisco J. Barrero [Espagne] ; Blas Morales [Espagne] ; Juan D. Luna [Espagne] ; Manuel Ramirez [Espagne] ; Francisco Vives [Espagne]Plasma α‐synuclein in patients with Parkinson's disease with and without treatment
000712 (2010) Michelangelo Bartolo [Italie] ; Mariano Serrao [Italie] ; Cristina Tassorelli [Italie] ; Romildo Don [Italie] ; Alberto Ranavolo [Italie] ; Francesco Draicchio [Italie] ; Claudio Pacchetti [Italie] ; Simona Buscone [Italie] ; Armando Perrotta [Italie] ; Anna Furnari [Italie] ; Placido Bramanti [Italie] ; Luca Padua [Italie] ; Francesco Pierelli [Italie] ; Giorgio Sandrini [Italie]Four‐week trunk‐specific rehabilitation treatment improves lateral trunk flexion in Parkinson's disease
000717 (2010) P. O. Valko ; D. Waldvogel ; M. Weller ; C. L. Bassetti [Suisse] ; U. Held ; C. R. BaumannFatigue and excessive daytime sleepiness in idiopathic Parkinson’s disease differently correlate with motor symptoms, depression and dopaminergic treatment
000736 (2010) Bonnie P. Hersh [États-Unis] ; Nancy L. Earl [États-Unis] ; Robert A. Hauser [États-Unis] ; Mark Stacy [États-Unis]Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "treatment" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "treatment" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    treatment
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024